Immunic reported $-22.78M in EBITDA for its fiscal quarter ending in June of 2024.





Ebitda Change Date
Alterity Therapeutics Limited AUD -7.72M 2.99M Jun/2023
BioMarin Pharmaceutical USD 146.05M 170.22M Mar/2026
Cipla INR 9.55B 3B Mar/2026
Clal Biotechnology ILS -5.3M 2.09M Dec/2022
Compugen USD -7.89M 536K Sep/2025
CSL USD 3.13B 1.17B Dec/2025
Grifols EUR 482.04M 7.04M Sep/2025
Immunic USD -22.78M 753K Jun/2024
Insmed USD -148.3M 165.88M Mar/2026
Omeros USD -47.96M 7.39M Sep/2023
OraSure Technologies USD -17.7M 4.06M Dec/2025
Quidel USD 108.7M 44.6M Mar/2026
Ultragenyx Pharmaceutical USD -99.43M 57.35M Dec/2025
United Therapeutics USD 379.5M 83.4M Dec/2025
Xoma USD 2.52M 7.98M Jun/2024